Interferon-induced growth arrest is mediated by membrane structural changes

Journal of Interferon and Cytokine Research

Volumn 17, Issue 11, 1997, Pages 701-706

  Guha, A ^a   Mason, R P ^b   Primorac, D ^a   Konopaske, G ^a   Miller, J ^a   Sinha, P ^a   Tulenko, T N ^b   Hand, A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL GROWTH; DNA DETERMINATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKEMIA; LIPID BILAYER; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL;

EID: 0030695360     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.701     Document Type: Article

References (23)

1. PESTKA, S., and LANGER, J.A. (1987). Interferons and their actions. Annu. Rev. Biochem. 56, 727-777.
2. FARRAR, M.A., and SCHREIBER, R.D. (1993). The molecular cell biology of IFN-γ and its receptor. Annu. Rev. Immunol. 11, 571-611.
3. WILLIAMS, J.G., JURKOVICH, G.J., and MAIER, R.V. (1993). Interferon-gamma: a key immunoregulatory lymphokine. J. Surg. Res. 54, 79-93.
4. GUHA, A., and CONE, R.E. (1991). Interferon retards the turnover of H-2Dd antigens by splenic lymphocytes. J. Immunol. 146, 1858-1861.
5. GUHA, A., DAINIAK, N., FREEDMAN, M., GOLDSCHNEIDER, I., and CONE, R.E. (1993). Regulatory effects of interferon-γ and phorbol esters on the surface expression and biosynthesis of MHC class I antigens by human leukemic cells. Cell. Immunol. 151, 404-413.
6. PFEIFFER, L.M. (Ed). (1987). Mechanisms of Interferon Action. CRC Press, Boca Raton, FL.
7. FELLOUS, M., NIR, U., WALLACE, D., MERLIN, G., RUBENSTEIN, M., and REVEL, M. (1982). Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 79, 3082-3086.
8. SHAPIRO, S.D., CAMPBELL, E.J., KOBIYASHI, D.K., and WELGUS, H.G. (1990). Immune modulation of metalloproteinase production in human macrophages. J. Clin. Invest. 86, 1204-1210.
9. GUHA, A., CONE, R.E., FREEDMAN, M.H., TUCK, D.P., and DAINIAK, N. (1992). Modulation of MHC glycoprotein and membrane burst promoting activity (mBPA) by interferon-gamma and phorbol esters. Exp. Hematol. 20, 659 (abstract).
10. GUHA, A., MASON, P.R., TUCK, D.P., CONE, R.E., and DAINIAK, N. (1994). Modulation of hematopoiesis by lymphocyte membrane-derived components. Leukemia 8, S227-229.
11. DAINIAK, N., MASON, P.R., and GUHA, A. (1993). Physical interaction of a negative regulator of erythropoiesis with the membrane lipid bilayer. In: The Negative Regulation of Hematopoiesis. Fundamental Aspects of Clinical Application. M. Guigon, F.M. LeMoine, N. Dainiak, A. Schechter, and A. Najman (eds.) Colloque Inserm 229:201, John Libbey Eurotext, Montrogue.
12. GUHA, A., DIBRINO, M., SHIELDS, M.J., TUCK, D., and COLIGAN, J.E. (1995). Leukemia cell-derived factor (LDF) induces hematopoiesis. Leukemia 9(Suppl), 102-105.
13. TRUBIANI, D., BOSEO, D., and PRIMIO, R. (1994). Interferon-γ induces programmed cell death in differentiated human leukemia B-cell lines. Exp. Cell Res. 215, 23-27.
14. NIEDERWIESSER, D., HAROLD, M., WOLOSZCZUK, W., AULITZKY, W., MEISTER, B., TILG, H., GASTL, G., BOWDEN, R., and HUBER, C. (1990). Endogenous IFN-γ during human bone marrow transplantation. Transplantation 50, 620-625.
15. BLACK, P. (1980). Shedding from the cell surface of normal and cancer cells. Adv. Cancer Res. 12, 75-99.
16. EMERSON, E., and CONE, R.E. (1981). I-K and H-2K antigens are shed as supramolecular particles in association with membrane lipids. J. Immunol. 127, 482-486.
17. CONE, R.E., and EMERSON, S.G. (1988). Dynamic aspects of the lymphocyte surface turnover and shedding of membrane protein. In: The Lymphocyte Structure and Function. J.J. Marchalonis (ed.) New York: Marcel Dekker, p. 55.
18. CHEN, M., MASON, R.P., and TULENKO, T.N. (1995). Atherosclerosis alters the composition, structure and function of arterial smooth muscle cell plasma membrane. Biochem. Biophys. Acta 1272, 101.
19. GLEASON, M.M., MEDOW, M.S., and TULENKO, T.N. (1991). Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells. Circ. Res. 69, 216-227.
20. STOVER, M.L., PRIMORAC, D., McKINSTRY, M., LIU, S.C., and ROWE, D.W. (1993). Defective splicing of α1(1) collagen in RNA in nondeforming (type 1) osteogenesis imperfecta. J. Clin. Invest. 92, 1994-2022.
21. MASON, R.P., GONJE, G.E., CHESTER, D.W., and HERBETTE, L.G. (1989). Partitioning and location of Bay K 8644, 1,4-dihydropyridine calcium channel agonist in model and biological lipid membranes. Biophys. J. 55, 769-778.
22. TUCK, D.P., CERRETTI, D.P., HAND, A., GUHA, A., SORBA, S., and DAINIAK, N. (1994). Human macrophage colony-stimulating factor is expressed at and shed from the cell surface. Blood 84, 2182-2188.
23. MOSSALAYI, M.D., and DEBRA, P. (1992). CD23: a cytokine with dual membrane and soluble forms. Res. Immunol. 143, 439-441.